Global Cancer Technology on Netcapital

GCT’s lead cancer technology is its remote-controlled cancer drug delivery platform.

Raise to date: $107,000

Reporting Date: 02/23/2020

Key Stats

Minimum Raise


Maximum Raise


Likelihood of Max Exceeded
Start Date


Stop Date


Days Remaining


Security Type

Common Stock

Investment Minimum


Deal Type

No Review

Investment Summary



# of Investors

Not Known

% of Minimum Raised


% of Maximum Raised


Dollars Per Day to Reach Max


DPD* Committed


DPD* Category


DPD* All Companies


Kingscrowd Momentum


Total Dollars Raised


Weekly Commitments ($)
Aggregate Commitments ($)

SEC Filing Data from Kingscrowd

Global Cancer Technology, with a post-money valuation of $11.6 million, is raising funds on NetCapital. It is an emerging medical technology company that may soon revolutionize cancer therapy. The technology of Global Cancer Technology is protected by several patents and is aimed at remote-controlled cancer drug delivery. Global Cancer Technology was founded by John P. Clark. The current round of crowdfunding has a minimum target of $10,000 and a maximum target of $107,000, and the proceeds will be used for pre-clinical work, research, marketing, commercialization, and general and administrative expenses. The technology of Global Cancer Technology was developed by scientists at Moores Cancer Center UC San Diego. Using the technology, the cancer drug will be attached to a nanocrystal scintillator and delivered to the body conveniently.